Risk of iodinated contrast material-induced nephropathy with intravenous administration

Richard W Katzberg, Brendan J. Barrett

Research output: Contribution to journalReview article

115 Scopus citations

Abstract

The apparently lower risk of contrast material (CM)-induced nephropathy associated with intravenous CM administration in clinical settings such as contrast-enhanced multidetector CT makes it defensible to consider using CM even in patients with greater levels of background risk factors (eg, greater degrees of preexisting chronic renal insufficiency) than one would be comfortable with in the intraarterial setting, as long as there is a clear indication for the diagnostic examination.

Original languageEnglish (US)
Pages (from-to)622-628
Number of pages7
JournalRadiology
Volume243
Issue number3
DOIs
StatePublished - Jun 2007

    Fingerprint

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this